Skip to content

Goldenwell Biotech, Inc.

GWLL

CIK 0001800373

← back to feed
Revenue (TTM)
$679
−99.5% YoY Q3 Dec 2025
Net Income (TTM)
−$24.52K
−532.2% YoY Q3 Dec 2025
EPS Diluted (TTM)
$0.00
Q3 Dec 2025
Gross Margin
9,204.7%
Q3 Dec 2025
Operating Margin
-9,167.5%
Q3 Dec 2025
Net Margin
-3,610.6%
Q3 Dec 2025
Free Cash Flow (TTM)
—
Q3 Dec 2025
Cash
$25.72K
Q3 Dec 2025
Total Debt
$176.09K
Q3 Dec 2025
Shares Outstanding
99M sh
Q3 Dec 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings